Dr Edward Ward Stevenson, MD | |
400 University Park Drive, Apt 194, Homewood, AL 35209 | |
(205) 871-6213 | |
Not Available |
Full Name | Dr Edward Ward Stevenson |
---|---|
Gender | Male |
Speciality | Otolaryngology |
Location | 400 University Park Drive, Homewood, Alabama |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1215257258 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207Y00000X | Otolaryngology | 2106 (Alabama) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr Edward Ward Stevenson, MD 400 University Park Drive, Apt 194, Homewood, AL 35209 Ph: (205) 871-6213 | Dr Edward Ward Stevenson, MD 400 University Park Drive, Apt 194, Homewood, AL 35209 Ph: (205) 871-6213 |
News Archive
The Senate Health, Education, Labor and Pensions Committee has moved to Thursday the confirmation hearing for Margaret Hamburg, President Obama's pick for FDA commissioner, citing the need to address the H1N1 influenza outbreak, the Wall Street Journal reports.
U.S. Marshals, at the request of the FDA, today seized all dietary supplements by a Wisconsin maker for false claims made about their safety and effectiveness in treating a number of diseases.
Negative school experiences can have harmful long term effects on pupils with Autism Spectrum Conditions, a new study in the journal Autism reports.
How do certain multiple myeloma treatment drugs cause complications? How does the immune system become dysfunctional due to cancer? How safe is a vaccine that could prevent development of precancerous colon polyps? Those are among the many questions that will be answered by researchers from the University of Pittsburgh Cancer Institute and the University of Pittsburgh School of Medicine during the American Association for Cancer Research 102nd Annual Meeting 2011, April 2 to 6, in Orlando, Fla.
Kamada, Ltd., a biopharmaceutical company engaged in development, production and marketing of specialty life-saving therapeutics and Baxter International Inc., a global, diversified healthcare company announced today that they have entered into an exclusive distribution and manufacturing agreement for Kamada's liquid, ready to use, intravenous Alpha-1 Antitrypsin Product for the treatment of hereditary Alpha-1 Antitrypsin Deficiency approved by the USFDA on July 1st, 2010 for marketing under the trade name "Glassia™".
› Verified 4 days ago
Dr. Brian J Mccool, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 3055 Independence Dr, Homewood, AL 35209 Phone: 205-414-1368 Fax: 205-414-1367 |